184 related articles for article (PubMed ID: 17334391)
1. A dual role for the API2 moiety in API2-MALT1-dependent NF-kappaB activation: heterotypic oligomerization and TRAF2 recruitment.
Lucas PC; Kuffa P; Gu S; Kohrt D; Kim DS; Siu K; Jin X; Swenson J; McAllister-Lucas LM
Oncogene; 2007 Aug; 26(38):5643-54. PubMed ID: 17334391
[TBL] [Abstract][Full Text] [Related]
2. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
Garrison JB; Samuel T; Reed JC
Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
[TBL] [Abstract][Full Text] [Related]
3. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.
Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M
J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209
[TBL] [Abstract][Full Text] [Related]
4. The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling.
Rosebeck S; Rehman AO; Apel IJ; Kohrt D; Appert A; O'Donnell MA; Ting AT; Du MQ; Baens M; Lucas PC; McAllister-Lucas LM
Oncogene; 2014 May; 33(19):2520-30. PubMed ID: 23770847
[TBL] [Abstract][Full Text] [Related]
5. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
Hosokawa Y
Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
[TBL] [Abstract][Full Text] [Related]
6. Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18) (q21;q21) MALT lymphoma.
Izumiyama K; Nakagawa M; Yonezumi M; Kasugai Y; Suzuki R; Suzuki H; Tsuzuki S; Hosokawa Y; Asaka M; Seto M
Oncogene; 2003 Nov; 22(50):8085-92. PubMed ID: 14603249
[TBL] [Abstract][Full Text] [Related]
7. Activation of NF-kappaB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis.
Stoffel A; Chaurushiya M; Singh B; Levine AJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9079-84. PubMed ID: 15184680
[TBL] [Abstract][Full Text] [Related]
8. API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-kappaB binding elements: evidence for a positive feed-back loop pathway resulting in unremitting NF-kappaB activation.
Hosokawa Y; Suzuki H; Nakagawa M; Lee TH; Seto M
Biochem Biophys Res Commun; 2005 Aug; 334(1):51-60. PubMed ID: 15982633
[TBL] [Abstract][Full Text] [Related]
9. API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis.
Rosebeck S; Lim MS; Elenitoba-Johnson KS; McAllister-Lucas LM; Lucas PC
World J Biol Chem; 2016 Feb; 7(1):128-37. PubMed ID: 26981201
[TBL] [Abstract][Full Text] [Related]
10. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
Varfolomeev E; Wayson SM; Dixit VM; Fairbrother WJ; Vucic D
J Biol Chem; 2006 Sep; 281(39):29022-9. PubMed ID: 16891304
[TBL] [Abstract][Full Text] [Related]
11. Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma.
Hosokawa Y; Suzuki H; Suzuki Y; Takahashi R; Seto M
Cancer Res; 2004 May; 64(10):3452-7. PubMed ID: 15150097
[TBL] [Abstract][Full Text] [Related]
12. Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment.
Rosebeck S; Lucas PC; McAllister-Lucas LM
Future Oncol; 2011 May; 7(5):613-7. PubMed ID: 21568677
[TBL] [Abstract][Full Text] [Related]
13. Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination.
Baens M; Fevery S; Sagaert X; Noels H; Hagens S; Broeckx V; Billiau AD; De Wolf-Peeters C; Marynen P
Cancer Res; 2006 May; 66(10):5270-7. PubMed ID: 16707452
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein.
Nakagawa M; Seto M; Hosokawa Y
Leukemia; 2006 Jun; 20(6):929-36. PubMed ID: 16572204
[TBL] [Abstract][Full Text] [Related]
15. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.
Ho L; Davis RE; Conne B; Chappuis R; Berczy M; Mhawech P; Staudt LM; Schwaller J
Blood; 2005 Apr; 105(7):2891-9. PubMed ID: 15598810
[TBL] [Abstract][Full Text] [Related]
16. Actvation of NF-kappaB by the API2/MALT1 fusions inhibits p53 dependant but not FAS induced apoptosis: a directional link between NF-kappaB and p53.
Stoffel A; Levine AJ
Cell Cycle; 2004 Aug; 3(8):1017-20. PubMed ID: 15280657
[TBL] [Abstract][Full Text] [Related]
17. Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity.
Zhou H; Du MQ; Dixit VM
Cancer Cell; 2005 May; 7(5):425-31. PubMed ID: 15894263
[TBL] [Abstract][Full Text] [Related]
18. The API2/MALT1 fusion product may lead to germinal center B cell lymphomas by suppression of apoptosis.
Stoffel A; Le Beau MM
Hum Hered; 2001; 51(1-2):1-7. PubMed ID: 11096264
[TBL] [Abstract][Full Text] [Related]
19. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.
Lucas PC; Yonezumi M; Inohara N; McAllister-Lucas LM; Abazeed ME; Chen FF; Yamaoka S; Seto M; Nunez G
J Biol Chem; 2001 Jun; 276(22):19012-9. PubMed ID: 11262391
[TBL] [Abstract][Full Text] [Related]
20. Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21).
Zhou Y; Ye H; Martin-Subero JI; Hamoudi R; Lu YJ; Wang R; Siebert R; Shipley J; Isaacson PG; Dogan A; Du MQ
Br J Haematol; 2006 Apr; 133(1):35-42. PubMed ID: 16512826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
